T. Rowe Price Associates’s Cambrex Corporation CBM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-634,286
| Closed | -$37.7M | – | 2584 |
|
|
2019
Q3 | $37.7M | Sell |
634,286
-7,865
| -1% | -$421K | 0.01% | 961 |
|
|
2019
Q2 | $30.1M | Sell |
642,151
-1,912
| -0.3% | -$80.2K | ﹤0.01% | 1049 |
|
|
2019
Q1 | $25M | Buy |
644,063
+4,830
| +0.8% | +$198K | ﹤0.01% | 1103 |
|
|
2018
Q4 | $24.1M | Buy |
639,233
+498
| +0.1% | +$25.2K | ﹤0.01% | 1088 |
|
|
2018
Q3 | $43.7M | Buy |
638,735
+34,377
| +6% | +$2.13M | 0.01% | 965 |
|
|
2018
Q2 | $31.6M | Buy |
604,358
+33,748
| +6% | +$1.68M | ﹤0.01% | 1048 |
|
|
2018
Q1 | $29.8M | Buy |
570,610
+2,945
| +0.5% | +$157K | ﹤0.01% | 1046 |
|
|
2017
Q4 | $27.2M | Buy |
567,665
+642
| +0.1% | +$31.8K | ﹤0.01% | 1080 |
|
|
2017
Q3 | $31.2M | Buy |
567,023
+36,622
| +7% | +$2.02M | 0.01% | 1028 |
|
|
2017
Q2 | $31.7M | Buy |
530,401
+20,921
| +4% | +$1.18M | 0.01% | 998 |
|
|
2017
Q1 | $28M | Buy |
509,480
+32,250
| +7% | +$1.72M | 0.01% | 1023 |
|
|
2016
Q4 | $25.7M | Buy |
477,230
+470
| +0.1% | +$22.6K | 0.01% | 1053 |
|
|
2016
Q3 | $21.2M | Buy |
476,760
+50,260
| +12% | +$2.45M | ﹤0.01% | 1107 |
|
|
2016
Q2 | $22.1M | Buy |
426,500
+20,990
| +5% | +$1M | ﹤0.01% | 1066 |
|
|
2016
Q1 | $17.8M | Buy |
405,510
+17,320
| +4% | +$683K | ﹤0.01% | 1118 |
|
|
2015
Q4 | $18.3M | Buy |
388,190
+60,780
| +19% | +$2.92M | ﹤0.01% | 1110 |
|
|
2015
Q3 | $13M | Buy |
327,410
+52,800
| +19% | +$2.47M | ﹤0.01% | 1239 |
|
|
2015
Q2 | $12.1M | Buy |
274,610
+80,600
| +42% | +$3.34M | ﹤0.01% | 1299 |
|
|
2015
Q1 | $7.69M | Buy |
194,010
+184,300
| +1,898% | +$5.45M | ﹤0.01% | 1400 |
|
|
2014
Q4 | $210K | Buy |
+9,710
| New | +$206K | ﹤0.01% | 2337 |
|
|
2014
Q3 | – | Sell |
-9,710
| Closed | -$201K | – | 2579 |
|
|
2014
Q2 | $201K | Buy |
+9,710
| New | +$197K | ﹤0.01% | 2345 |
|
Other funds holding CBM
T. Rowe Price Associates's CBM Position: Q4 2019 in Review
T. Rowe Price Associates sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 634,286 shares — an estimated $37.7M sold.
T. Rowe Price Associates first reported a position in CBM in Q2 2014 and held it in 21 quarters. The position peaked at $43.7M in Q3 2018. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.
- T. Rowe Price Associates reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
- T. Rowe Price Associates sold 634,286 Cambrex Corporation shares in Q4 2019, an estimated $37.7M.
- T. Rowe Price Associates first reported a position in Cambrex Corporation in Q2 2014 and held it in 21 quarters.
- T. Rowe Price Associates's Cambrex Corporation position peaked at $43.7M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.
Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.